Impact of COVID-19 on Drug Development in Rare Disease and Oncology
The full effect of the COVID-19 pandemic, particularly on the search for rare disease and oncology treatments, is still uncertain. What we do know is that patients diagnosed with these conditions simply cannot afford delays. With a patient-centric approach and guided by the best minds in the industry, Parexel has a broad perspective to help sponsors, regulators, and patients during this difficult time. We have learned a great deal over the past few months about trial conduct, patient recruitment, risk mitigation, the pace of regulatory approvals, and how patients are faring. And now we want to share this information with you.
Related Insights
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Advancing mRNA-based drug development and vaccine manufacturing
Jul 1, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Related Insights
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Advancing mRNA-based drug development and vaccine manufacturing
Jul 1, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024